SearcharxivSearch

arXiv · 2608.28030

Expanding the Human Ancestry Ontology to include under-represented populations and ethnicities for broader utility in annotations

Abstract

Successful discovery, integration and reuse of data relies on the availability of rich, well-structured and machine-readable metadata to describe every aspect of the data, from sample sources to collection processes to experimental protocols. The use of standardised terminologies to express concepts in a harmonised fashion lies at the core of high-quality data annotation, increasing the FAIRness of the data, facilitating data integration and promoting reproducibility. Here, we describe the Human Ancestry Ontology (HANCESTRO), originally developed to improve standardised reporting of genetic ancestry genomic resources such as the NHGRI-EBI GWAS Catalog and the Human Cell Atlas through high-level population descriptors, and more recently expanded to include diverse and previously under-represented populations in genomics and genetics research. HANCESTRO provides a framework for population descriptors that includes both ancestry based on the analysis of genetic information and self-reported ethnicity, which is based on social and cultural factors that don't necessarily align with genetic populations. By enabling the accurate and interoperable representation of population-related data, it promotes inclusive, representative and reproducible science.

Explore related subjects

Keep this discovery

BibTeXRIS

Anita Caron, Melek Chaouch, Zoë May Pendlington, Helen Parkinson, Danielle Welter. 2026-08-28. Expanding the Human Ancestry Ontology to include under-represented populations and ethnicities for broader utility in annotations. https://arxiv.org/abs/2608.28030

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

MarkerScout: A Disease-Agnostic Machine Learning Framework for Biomarker Prediction from Multi-Scale Mechanistic Models

We demonstrate the framework on three infectious diseases derived from a companion mechanistic immune-simulation platform: SARS-CoV-2, Influenza A Virus, and Plasmodium falciparum. Each disease was evaluated across hospitalization and intensive care unit cohorts, yielding six cohorts in total. Best-pipeline cross-validated macro F1 ranged from 0.82 for IAV-HOSP to 0.99 for COV-ICU, and the framework produced tiered, direction-aware biomarker lists for each disease and phase. Interleukin-18 (IL-18) reached the strongest tier in both SARS-CoV-2 phases with consistent direction. When benchmarked against three separate, independently collected clinical ICU datasets, MarkerScout's top-ranked features outperformed 94.4% of randomly selected feature sets of equivalent size for SARS-CoV-2, with a weaker but directionally consistent advantage for Influenza A Virus (66.7%) and Plasmodium falciparum (60.7%).

q-bio.OT

Enhancing Clinical Decision Support and Differential Diagnosis with Knowledge Graphs, and Retrieval Augmented Generation in Generative AI

Diagnostic error carries a burden, while unconstrained large language models (LLMs) remain vulnerable to hallucination and weak integration of quantitative laboratory dynamics. We developed a decision-support pipeline combining disease-specific biomarker correlation graphs, ordinary differential equations (ODEs), deep sequence classification, and retrieval-augmented generation (RAG). For 103 disease classes from a full blood count (FBC) repository, biomarker networks were used as coupling matrices to generate 30 trajectories per disease (3,090 total). A one-dimensional convolutional neural network (CNN) and long short-term memory (LSTM) network classified disease trajectories and six dynamical clusters. A constrained GPT-4o-mini RAG layer used a 19-pattern BMJ Best Practice/NICE corpus to generate differential diagnoses evaluated for diagnostic suitability, evidential grounding, and clinical plausibility. Across five random-seed runs, disease-level accuracy was $0.940 \pm 0.006$ for the CNN (95\% CI 0.933--0.948) and $0.852 \pm 0.019$ for the LSTM (95\% CI 0.828--0.875); the CNN advantage was 8.87 percentage points (95\% CI 6.47--11.27; $t(4)=10.26$, $p=5.1\times10^{-4}$; Hedges' $g=3.67$). Among 100 sampled RAG cases, 96 parsed successfully; evidence was cited in 97.9\%, the true diagnosis was mentioned in 71.9\%, and the composite score was 3.82/5 with a 47.9\% strict pass rate. The central finding was a decoupling between grounding and diagnostic correctness: classifier-correct versus classifier-wrong outputs differed in diagnostic suitability but not evidential grounding. Post-hoc analysis confirmed a 1.02-point diagnostic-score difference (Mann--Whitney $p=0.0024$; Hedges' $g=0.72$), whereas grounding differed by only $-0.02$ points ($p=0.839$; $g=-0.04$).

q-bio.OT

Geochemical Hazard Assessment of Martian Regolith for Future Human Exploration

As human missions to Mars move from concept to planning to reality, a systematic quantitative health risk assessment of martian regolith exposure has become critically important. This study presents a comprehensive multi-element, multi-pathway health hazard analysis of martian regolith for a 70 kg adult astronaut on an 18-month surface mission, using bulk silicate Mars geochemical data and Earth Upper Continental Crust reference values as baseline comparators. We computed Average Daily Dose, Hazard Quotient, Hazard Index, Enrichment Factor, Ecological Risk Factor, and Incremental Lifetime Cancer Risk across all three exposure pathways (oral ingestion, inhalation, and dermal contact) for toxic and heavy metals, under four filtration scenarios (0%, 25%, 50%, 95%). Results demonstrate that Cr and Co represent the most critical non-carcinogenic hazards, exceeding the regulatory threshold (HI > 1) even at 50% filtration, while Cr also poses the most significant carcinogenic risk, near the $10^{-4}$ regulatory threshold level. At least 92% regolith filtration efficiency is required to reduce Cr to acceptable non-cancer hazard levels. Nickel exceeds the acceptable cancer risk threshold of $10^{-6}$ at all filtration levels below 95%. No element other than Cr and Co exceeds HI = 1 in the unfiltered scenario, although Fe, Ni and Mn approach concerning levels. These results establish that a minimum 95% High-Efficiency Particulate Air (HEPA)-grade filtration efficiency combined with active chemical sorption is required for acceptable Cr and Co short term exposure and Cr, Ni long term exposure management. This study provides a pathway-specific quantitative risk framework applicable to habitat air quality standards and EVA suit specifications for Mars surface operations

q-bio.OT